Arcturus Therapeutics Holdings Inc Asset Turnover Ratio (ARCT), as of third quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Arcturus Therapeutics Holdings Inc   (NASDAQ: ARCT)
 

Arcturus Therapeutics Holdings Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Arcturus Therapeutics Holdings Inc asset turnover ratio, the ability of Arcturus Therapeutics Holdings Inc 's assets to generate revenue in the third quarter 2026, increased sequentially to 0.13 in the third quarter (Sep 30 2026), yet the ratio remained below the average, as ARCT's position remain challenging.

Within sector 68 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 1779 to 1910.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ARCT Asset Turnover Ratio (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Asset Change -23.74 % -27.47 % -26.03 % -14.06 % -17.24 %
Y / Y Revenue Change 6.68 % -89.54 % -92.99 % -68.39 % -58.84 %
Asset Turnover Ratio (TTM) 0.13 0.11 0.2 0.27 0.32
ARCT's Total Ranking # 1910 # 1779 # 1981 # 2404 #
Seq. Asset Change -4.01 % -8.6 % -9.49 % -3.97 % -8.71 %
Seq. Revenue Change 518.35 % 43.57 % -71.36 % -58.04 % -39.4 %



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 69
Healthcare Sector # 220
Overall Market # 1910

Asset Turnover Ratio Statistics
High Average Low
76.68 10.75 3.84
(Dec 31 2022)   (Mar 31 2021)




ARCT Company Profile • Back to ARCT Efficiency Comparisons • Compare ARCT Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2026 Assets at quarter ending Sep 30 2026
Bausch and Lomb Corp  0.39 $ 5,418.000  Millions$ 13,905.000  Millions
Ptc Therapeutics inc   0.38 $ 1,155.554  Millions$ 3,056.516  Millions
Regenxbio Inc   0.37 $ 153.911  Millions$ 411.896  Millions
Beta Bionics Inc   0.37 $ 127.899  Millions$ 342.326  Millions
Rxsight Inc   0.37 $ 122.088  Millions$ 327.231  Millions
Sotera Health Company  0.37 $ 1,230.250  Millions$ 3,298.320  Millions
Biomarin Pharmaceutical Inc  0.37 $ 3,655.127  Millions$ 9,869.428  Millions
Intelligent Bio Solutions Inc   0.37 $ 4.495  Millions$ 12.169  Millions
Xilio Therapeutics Inc   0.36 $ 55.010  Millions$ 151.815  Millions
Aquestive Therapeutics Inc   0.35 $ 48.837  Millions$ 138.245  Millions
Teva Pharmaceutical Industries Limited  0.35 $ 14,020.000  Millions$ 40,171.750  Millions
Profound Medical Corp   0.35 $ 23.627  Millions$ 67.868  Millions
Biogen Inc   0.33 $ 10,297.300  Millions$ 30,765.825  Millions
Krystal Biotech Inc   0.32 $ 470.025  Millions$ 1,454.366  Millions
Hyperfine Inc   0.31 $ 18.537  Millions$ 59.098  Millions
Orasure Technologies Inc  0.31 $ 116.113  Millions$ 373.089  Millions
Pfizer Inc  0.31 $ 63,625.000  Millions$ 205,363.250  Millions
Cardiff Lexington Corporation  0.30 $ 9.066  Millions$ 30.160  Millions
Ionis Pharmaceuticals Inc   0.30 $ 960.091  Millions$ 3,220.224  Millions
Adc Therapeutics Sa  0.30 $ 84.873  Millions$ 287.472  Millions
Sonida Senior Living Inc   0.29 $ 638.130  Millions$ 2,170.454  Millions
Fulgent Genetics Inc   0.29 $ 329.873  Millions$ 1,134.512  Millions
Waters Corporation  0.29 $ 5,611.362  Millions$ 19,618.388  Millions
Orchestra Biomed Holdings Inc   0.28 $ 31.206  Millions$ 109.738  Millions
Amarin Corp Plcuk  0.27 $ 176.609  Millions$ 643.746  Millions
Repligen Corp  0.27 $ 805.610  Millions$ 2,939.265  Millions
Humacyte Inc   0.27 $ 32.703  Millions$ 122.646  Millions
Neogen Corporation  0.26 $ 884.120  Millions$ 3,363.009  Millions
Autolus Therapeutics Plc  0.26 $ 137.434  Millions$ 533.104  Millions
Cryoport inc   0.25 $ 192.439  Millions$ 758.937  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.